Our results demonstrated the ability of GnRH-AIF chimeric proteins to target, enter, and kill specifically and efficiently human cancer cells overexpressing GnRH-R by causing caspase-independent, apoptotic death, as an innovative approach to the targeted treatment of solid cancers. This evidence concerns the gene GNRH1 and cancer.